77 related articles for article (PubMed ID: 3490260)
1. Enhancement by interleukin-1 (IL-1) of plasminogen activator inhibitor (PA-I) activity in cultured human endothelial cells.
Grames M; Breviario F; Pintucci G; Millet I; Dejana E; van Damme J; Donati MB; Mussoni L
Biochem Biophys Res Commun; 1986 Sep; 139(2):720-7. PubMed ID: 3490260
[TBL] [Abstract][Full Text] [Related]
2. Human endothelial cells produce a plasminogen activator inhibitor and a tissue-type plasminogen activator-inhibitor complex.
Philips M; Juul AG; Thorsen S
Biochim Biophys Acta; 1984 Nov; 802(1):99-110. PubMed ID: 6435688
[TBL] [Abstract][Full Text] [Related]
3. Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitor.
Nachman RL; Hajjar KA; Silverstein RL; Dinarello CA
J Exp Med; 1986 Jun; 163(6):1595-600. PubMed ID: 3086483
[TBL] [Abstract][Full Text] [Related]
4. Thrombin induction of plasminogen activator-inhibitor in cultured human endothelial cells.
Gelehrter TD; Sznycer-Laszuk R
J Clin Invest; 1986 Jan; 77(1):165-9. PubMed ID: 2418059
[TBL] [Abstract][Full Text] [Related]
5. In vitro effects of interleukin 1 on the synthesis of metalloproteases, TIMP, plasminogen activators and inhibitors in human articular cartilage.
Martel-Pelletier J; Zafarullah M; Kodama S; Pelletier JP
J Rheumatol Suppl; 1991 Feb; 27():80-4. PubMed ID: 1851231
[TBL] [Abstract][Full Text] [Related]
6. Fibrinolytic properties of a human endothelial hybrid cell line (Ea.hy 926).
Emeis JJ; Edgell CJ
Blood; 1988 Jun; 71(6):1669-75. PubMed ID: 3130908
[TBL] [Abstract][Full Text] [Related]
7. Butyrate stimulates tissue-type plasminogen-activator synthesis in cultured human endothelial cells.
Kooistra T; van den Berg J; Töns A; Platenburg G; Rijken DC; van den Berg E
Biochem J; 1987 Nov; 247(3):605-12. PubMed ID: 2827633
[TBL] [Abstract][Full Text] [Related]
8. The active and the inactive plasminogen activator inhibitor from human endothelial cell conditioned medium are immunologically and functionally related to each other.
Sprengers ED; van Hinsbergh VW; Jansen BG
Biochim Biophys Acta; 1986 Sep; 883(2):233-41. PubMed ID: 3091077
[TBL] [Abstract][Full Text] [Related]
9. Regulation of plasminogen activation, matrix metalloproteinases and urokinase-type plasminogen activator-mediated extracellular matrix degradation in human osteosarcoma cell line MG63 by interleukin-1 alpha.
de Bart AC; Quax PH; Löwik CW; Verheijen JH
J Bone Miner Res; 1995 Sep; 10(9):1374-84. PubMed ID: 7502710
[TBL] [Abstract][Full Text] [Related]
10. Modulation of mRNA levels for urinary- and tissue-type plasminogen activator and plasminogen activator inhibitors 1 and 2 in human fibroblasts by interleukin 1.
Michel JB; Quertermous T
J Immunol; 1989 Aug; 143(3):890-5. PubMed ID: 2501387
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor induction of urokinase-type plasminogen activator in human endothelial cells.
Niedbala MJ; Stein M
Biomed Biochim Acta; 1991; 50(4-6):427-36. PubMed ID: 1801706
[TBL] [Abstract][Full Text] [Related]
12. Isolation of tissue-type plasminogen activator-inhibitor complexes from human plasma. Evidence for a rapid plasminogen activator inhibitor.
Thorsen S; Philips M
Biochim Biophys Acta; 1984 Nov; 802(1):111-8. PubMed ID: 6435684
[TBL] [Abstract][Full Text] [Related]
13. Gamma-interferon counteracts interleukin-1 alpha stimulated expression of urokinase-type plasminogen activator in human endothelial cells in vitro.
Wojta J; Zoellner H; Gallicchio M; Hamilton JA; McGrath K
Biochem Biophys Res Commun; 1992 Oct; 188(1):463-9. PubMed ID: 1384490
[TBL] [Abstract][Full Text] [Related]
14. Interferon-alpha 2 counteracts interleukin-1 alpha-stimulated expression of urokinase-type plasminogen activator in human foreskin microvascular endothelial cells in vitro.
Wojta J; Zoellner H; Gallicchio M; Filonzi EL; Hamilton JA; McGrath K
Lymphokine Cytokine Res; 1994 Apr; 13(2):133-8. PubMed ID: 8061114
[TBL] [Abstract][Full Text] [Related]
15. The formation of complexes between human plasminogen activator inhibitor-1 (PAI-1) and sodium dodecyl sulfate: possible implication in the functional properties of PAI-1.
Gaussem P; Anglés-Cano E
Biochim Biophys Acta; 1991 Sep; 1079(3):321-9. PubMed ID: 1911857
[TBL] [Abstract][Full Text] [Related]
16. Rapid inactivation of the plasminogen-activator inhibitor upon secretion from cultured human endothelial cells.
Kooistra T; Sprengers ED; van Hinsbergh VW
Biochem J; 1986 Nov; 239(3):497-503. PubMed ID: 3103601
[TBL] [Abstract][Full Text] [Related]
17. Production of proteases type plasminogen activator and their inhibitor in cornea.
Mirshahi M; Mirshahi S; Soria C; Soria J; Thomaidis A; Pouliquen Y; Faure JP
Biochem Biophys Res Commun; 1989 May; 160(3):1021-5. PubMed ID: 2499321
[TBL] [Abstract][Full Text] [Related]
18. Effect of thrombin on the production of plasminogen activators and PA inhibitor-1 by human foreskin microvascular endothelial cells.
Van Hinsbergh VW; Sprengers ED; Kooistra T
Thromb Haemost; 1987 Apr; 57(2):148-53. PubMed ID: 3496679
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-1beta regulates urokinase plasminogen activator (u-PA), u-PA receptor, soluble u-PA receptor, and plasminogen activator inhibitor-1 messenger ribonucleic acid expression in cultured human endometrial stromal cells.
Chung HW; Wen Y; Ahn JJ; Moon HS; Polan ML
J Clin Endocrinol Metab; 2001 Mar; 86(3):1332-40. PubMed ID: 11238529
[TBL] [Abstract][Full Text] [Related]
20. Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation.
Colucci M; Paramo JA; Collen D
J Clin Invest; 1985 Mar; 75(3):818-24. PubMed ID: 3920245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
